These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Listed as ongoing, but also has a completion date and reported results 2004-000134-37 Trial to Reduce Cardiovascular Events with Aranesp Therapy 2009-03-28 bad-data
Listed as ongoing, but also has a completion date and reported results 2004-000138-35 A Study to Evaluate AMG 162 in the treatment of Postmenopausal Osteoporosis 2008-10-14 bad-data
Listed as ongoing, but also has a completion date and reported results 2004-000172-13 AN OPEN LABEL STUDY EVALUATING THE SAFETY AND EFFICACY OF LONG-TERM DOSING OF AMG 531 IN THROMBOCYTOPENIC SUBJECTS WITH IMMUNE (IDIOPATHIC) THROMBOCITOPENIC PURPURA 2010-01-26 bad-data
Listed as ongoing, but also has a completion date and reported results 2004-000173-65 A Randomized, Placebo Controlled Study Evaluating the Efficacy and Safety of AMG 531 Treatment of Thrombocytopenic Subjects with Immune (Idiopathic) Thrombocytopenic Purpura (ITP) Prior to Splenectomy 2006-12-21 bad-data
Listed as ongoing, but also has a completion date and reported results 2004-000174-31 A Randomized, Placebo Controlled Study Evaluating the Efficacy and Safety of AMG 531 Treatment of Thrombocytopenic Subjects with Immune (Idiopathic) Thrombocytopenic Purpura (ITP) Refractory to Splene... 2006-09-05 bad-data
Listed as ongoing, but also has a completion date and reported results 2004-000509-24 A randomised active controlled study of AMG 162 in breast cancer subjects with bone metastases who have not previously been treated with bisphosphonate therapy 2006-06-15 bad-data
Completed, but no date, and reported results 2004-000511-25 A Randomized, Open Label, Active Controlled Study of AMG 162 in Subjects with Advanced Cancer Currently Being Treated with Intravenous Bisphosphonates bad-data
Reported results 2004-000512-17 A Randomized, Double-Blind, Placebo-controlled Study to Evaluate AMG 162 in the Treatment of Bone Loss in Subjects Undergoing Androgen-Deprivation Therapy for Non-metastatic Prostate Cancer 2008-05-14 due-trials
Ongoing 2004-000645-37 A Randomised, Multi-Center, Double-Blind, Placebo-Controlled, Dose-Finding Study of AMG 114 Administered by Subcutaneous Injection for the Treatment of Anemia in Subjects With Non-myeloid Malignancies... not-yet-due
Reported results 2004-001154-86 A Multicenter, Double-blind, Placebo-controlled Roll-over Study to Protocol 20010103 of Darbepoetin Alfa for the Treatment of Anemia of Cancer 2007-01-17 due-trials
Listed as ongoing, but also has a completion date and reported results 2004-001417-33 A Randomized Open-Label Study of Darbepoetin alfa Administered Every Three Weeks with or without Parenteral Iron in Anemic Subjects with Nonmyeloid Malignancies Receiving Chemotherapy 2006-08-01 bad-data
Listed as ongoing, but also has a completion date and reported results 2004-002016-28 A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Weekly Doses of Palifermin (Recombinant Human Keratinocyte Growth Factor, rHuKGF) for the Reduction... 2016-07-11 bad-data
Reported results 2004-002165-20 An open label study of AMG 706 in subjects with advanced gastrointestinal stromal tumors (GISTs) who developed progressive disease or relapsed while on Imatinib Mesylate. 2007-03-07 due-trials
Ongoing, reported early 2004-002310-10 Study to Investigate Cinacalcet Treatment in Haemodialysis Patients with Secondary Hyperparathyroidism not-yet-due
Listed as ongoing, but also has a completion date and reported results 2004-004178-10 A Randomized, Double-Blind, Equivalence Study of the Efficacy of Darbepoetin Alfa Manufactured by Serum Free Bioreactor Technology and Darbepoetin Alfa Manufactured by Roller-Bottle Technology for the... 2006-05-24 bad-data
Reported results 2004-004499-35 A Study to Evaluate the Efficacy of Converting from Intravenous or Subcutaneous rHuEPO to Intravenous Darbepoetin Alfa (Aranesp®) in Subjects with Chronic Kidney Disease Receiving Haemodialysis 2006-10-05 due-trials
Ongoing 2004-004558-18 A Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of Cinacalcet HCl in Chronic Kidney Disease Subjects with Secondary Hyperparathyroidism Not Receiving Dialysis not-yet-due
Reported results 2004-005007-14 A Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of Palifermin (Recombinant Human Keratinocyte Growth Factor) for Reduction of Oral Mucositis in Subjects with St... 2014-03-31 due-trials
Completed, report not yet due 2004-005252-14 Direct Inhibition of δ Protein Kinase C Enzyme to Limit Total Infarct Size in Acute Myocardial Infarction (DELTA MI): Intracoronary KAI-9803 for Injection as an Adjunct to Primary Percutaneous Coronar... 2006-11-28 not-yet-due
Reported results 2005-000213-35 A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Weekly Doses of Palifermin (Recombinant Human Keratinocyte Growth Factor, rHuKGF) for the Reductio... 2017-07-11 due-trials
Reported results 2005-001618-42 A Phase 2, Open-label Study of AMG 706 to Treat Subjects with Locally Advanced or Metastatic Thyroid Cancer 2007-03-13 due-trials
Listed as ongoing, but also has a completion date and reported results 2005-003558-83 A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Subcutaneous AMG 108 in Subjects with Rheumatoid Arthritis. 2008-02-06 bad-data
Listed as ongoing, but also has a completion date and reported results 2005-004323-18 An Open Label Study Treatment Extension Study of AMG 706 2012-07-16 bad-data
Ongoing, reported early 2005-004642-14 Estudio abierto, de un solo grupo, de palifermin para la reducción de la mucositis en sujetos con linfoma no Hodgkin (LNH) o mieloma múltiple (MM) sometidos a quimioterapia a altas dosis y trasplante ... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2005-004643-53 Bone Histomorphometry Assessment For Dialysis Patients with Secondary Hyperparathyroidism of End Stage Renal Disease 2011-05-13 bad-data
Listed as ongoing, but also has a completion date and reported results 2005-004676-20 A Randomized, Multicenter Phase 3 Study to Compare the Efficacy of Panitumumab in Combination with Chemotherapy to the Efficacy of Chemotherapy Alone in Patients with Previously Treated Metastatic Co... 2010-09-13 bad-data
Listed as ongoing, but also has a completion date and reported results 2005-005081-37 A Randomized, Double-Blind Study to Compare the Efficacy of Treatment with Denosumab versus Alendronate Sodium in Postmenopausal Women with Low Bone Mineral Density 2007-11-21 bad-data
Completed, but no date, and reported results 2005-005271-15 A Multicenter, Randomized Placebo Controlled Pilot MicroCT Study to Estimate the Effect of Treatment with Denosumab (AMG 162) and Alendronate Sodium in Postmenopausal Women with Low Bone Mineral Densi... bad-data
Ongoing 2005-005275-15 A Randomized, Double- Blind, Placebo- Controlled, Multi- Center Phase 3 Study to Determine the Treatment Effect of Denosumab in Subjects with Non- Metastatic Breast Cancer Receiving Aromatase Inhibito... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2005-005278-59 A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Darbepoetin alfa Treatment on Mortality and Morbidity in Heart Failure (HF) Subjects with Symptom... 2012-10-11 bad-data
Listed as ongoing, but also has a completion date and reported results 2005-005484-28 A Multicenter, Open Label, Randomized Study of AMG 951 in Subjects with Previously Untreated Stage IIIb/IV Non-Small Cell Lung Cancer (NSCLC) Treated with Chemotherapy with or without Bevacizumab 2011-11-14 bad-data
Listed as ongoing, but also has a completion date and reported results 2005-005485-37 A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Phase 3 Study of Denosumab on Prolonging Bone Metastasis-Free Survival in Men with Hormone-refractory Prostate Cancer 2014-04-09 bad-data
Reported results 2006-000074-79 A Multicenter, Single Arm Study Evaluating The Extension From Weekly To Once Every Other Week Darbepoetin Alfa Administration In Subjects With Chronic Kidney Disease Receiving Dialysis 2007-06-05 due-trials
Reported results 2006-000091-32 A Randomized Phase 2 Trial of Double- Blind, Placebo Controlled AMG 706 in Combination with Paclitaxel, or Open- Label Bevacizumab in Combination with Paclitaxel, as First Line Therapy in Women with H... 2012-05-30 due-trials
Listed as ongoing, but also has a completion date and reported results 2006-000144-92 An Open Label, Sequential Cohort, Dose Escalation Study to Evaluate the Safety and Efficacy of AMG 531 in Thrombocytopenic Subjects with Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS) 2008-06-10 bad-data
Listed as ongoing, but also has a completion date and reported results 2006-000170-70 A Randomized, Multicenter, Phase 3 Study to Compare the Efficacy of Panitumumab in Combination with Oxaliplatin/ 5-fluorouracil/ leucovorin to the Efficacy of Oxaliplatin/ 5-fluorouracil/ leucovorin... 2013-01-10 bad-data
Listed as ongoing, but also has a completion date and reported results 2006-000339-93 A Randomized, Double-Blind, Multicenter Study of Denosumab Compared with Zoledronic Acid (Zometa) in the Treatment of Bone Metastases in Subjects with Advanced Breast Cancer. 2012-04-04 bad-data
Listed as ongoing, but also has a completion date and reported results 2006-000341-19 A Randomized, Double-Blind, Multicenter Study of Denosumab Compared with Zoledronic Acid (Zometa) in the Treatment of Bone Metastases in Men with Hormone-Refractory Prostate Cancer 2012-02-27 bad-data
Listed as ongoing, but also has a completion date and reported results 2006-000848-65 A Randomized, Double-Blind, Multicenter Study of Denosumab Compared With Zoledronic Acid Zometa 63720; in the Treatment of Bone Metastases in Subjects with Advanced Cancer Excluding Breast and Pro... 2009-10-14 bad-data
Reported results 2006-000849-19 A Randomized Study to Evaluate Safety and Efficacy of Transitioning Therapy from Alendronate to Denosumab AMG 162 in Postmenopausal Women with Low Bone Mineral Density 2008-03-18 due-trials
Listed as ongoing, but also has a completion date and reported results 2006-002075-40 EVOLVE Evaluation of Cinacalcet HCI Therapy to lower CardioVascular events. 2012-03-21 bad-data
Reported results 2006-002662-19 ADVANCE - A Randomized Study to Evaluate the Effects of Cinacalcet Plus Low Dose Vitamin D on Vascular Calcification in Subjects with Chronic Kidney Disease (CKD) Receiving Hemodialysis 2009-05-15 due-trials
Listed as ongoing, but also has a completion date and reported results 2006-003173-27 A Multicenter, Randomized, Double-blind Study Comparing De Novo Once Monthly and Once Every 2 Week Darbepoetin alfa Dosing for the Correction of Anemia in Subjects With Chronic Kidney Disease Not Rece... 2012-04-10 bad-data
Listed as ongoing, but also has a completion date and reported results 2006-003698-29 A long term assessment of safety and physical function with AMG 108 subcutaneous monthly treatment in subjects with Rheumatoid Arthritis 2008-03-19 bad-data
Reported results 2006-003699-36 A Phase 2, Randomized, Double Blind, Placebo- Controlled Dose and Schedule Finding Trial to Evaluate the Safety and Efficacy of AMG 531 for Treatment of Chemotherapy- Induced Thrombocytopenia in Subje... 2008-12-02 due-trials
Listed as ongoing, but also has a completion date and reported results 2006-003700-18 A Randomized, Controlled, Open- label Study Evaluating the Efficacy and Tolerability of AMG 531 versus Medical Standard of Care as Chronic Therapy for Non-splenectomized Subjects with Immune (Idiopath... 2009-11-05 bad-data
Reported results 2006-003709-15 A Double-Blind, Randomized, Placebo-controlled Study of Two Different Schedules of Palifermin Pre- and Post Chemotherapy and Pre-Chemotherapy only for Reduction in Severity of Oral Mucositis in Subj... 2011-11-22 due-trials
Listed as ongoing, but also has a completion date and reported results 2006-003784-32 A Phase 3, Multicenter, Randomized, Placebo Controlled, Double Blind Trial of AMG 706 in Combination With Paclitaxel and Carboplatin for Advanced Non small Cell Lung Cancer 2012-12-13 bad-data
Completed, but no date, and reported results 2006-003785-33 A Global, Multicenter, Open-label, Single Agent, Two-stage Phase 2 Study to Evaluate the Efficacy and Safety of AMG 102 in Subjects With Advanced Renal Cell Carcinoma bad-data
Listed as ongoing, but also has a completion date and reported results 2006-003786-13 A Phase 3 Randomized Trial of Chemotherapy With or Without Panitumumab in Patients with Metastatic and/or Recurrent Squamous Cell Carcinoma of the Head and Neck 2012-03-12 bad-data
Reported results 2006-006520-19 An open-label, multicenter phase II study to investigate the efficacy, safety, and tolerability of the bi-specific T-cell engager (BITE) MT103 in patients with minimal residual disease (MRD) of positi... 2014-11-26 due-trials
Listed as ongoing, but also has a completion date and reported results 2006-006658-89 A Phase 1b/2 study of AMG 655 Combination with Paclitaxel and Carboplatin for the First-Line Treatment of Advanced Non-Small Cell Lung Cancer 2011-03-23 bad-data
Listed as ongoing, but also has a completion date and reported results 2006-006739-36 A Single Arm Multicentre Phase II Study of Panitumumab in Combination with Irinotecan/5-Fluorouracil/Leucovorin in Patients with Metastatic Colorectal Cancer 2012-08-02 bad-data
Ongoing, reported early 2006-006964-48 An Open-Label, Multi-Center, Phase 2 Safety and Efficacy Study of Denosumab (AMG 162) in Subjects with Recurrent or Unresectable Giant Cell Tumor (GCT) of Bone not-yet-due
Listed as ongoing, but also has a completion date and reported results 2007-000147-98 A Randomized, Double Blinded, Multi-Center Phase 2 Study to Estimate the Efficacy and Evaluate the Safety and Tolerability of Sorafenib in Combination with AMG 386 or Placebo in Subjects with Metastat... 2014-06-10 bad-data
Not reported 2007-000570-22 A Randomized, Double-Blind, Trial of AMG 745 or Placebo for the Treatment of Cachexia in Subjects with Non-Small Cell Lung Cancer 2008-01-10 due-trials
Listed as ongoing, but also has a completion date and reported results 2007-000573-29 A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Using Cinacalcet to Correct Hypercalcemia in Renal Transplant Recipients With Autonomous Hyperparathyroidism 2013-06-17 bad-data
Reported results 2007-000638-37 An open label study of AMG531 in severely refractory thrombocytopenic subjects with immune (idiopathic) Thrombocytopenic Purpura (ITP) 2011-01-05 due-trials
Listed as ongoing, but also has a completion date and reported results 2007-001041-17 An open label, single arm, extension study to evaluate the long term safety and sustained efficacy of Denosumab (AMG 162) in the treatment of postmenopausal osteoporosis. 2015-06-19 bad-data
Listed as ongoing, but also has a completion date and reported results 2007-001438-15 A Phase 2 Randomized Trial of Radiotherapy Plus Panitumumab Compared to Chemoradiotherapy in Subjects with Unresected, Locally Advanced Squamous Cell Carcinoma of the Head and Neck 2011-12-16 bad-data
Listed as ongoing, but also has a completion date and reported results 2007-001439-74 A Phase 2, Randomized Trial of Chemoradiation with or without Panitumumab in Subjects with Unresected, Locally Advanced Squamous Cell Carcinoma of the Head and Neck 2011-04-26 bad-data
Listed as ongoing, but also has a completion date and reported results 2007-001516-24 An Open Label Extension Study Evaluating the Safety of Long Term Dosing of AMG 531 in Thrombocytopenic Subjects with Myelodysplastic Syndromes (MDS) 2011-09-28 bad-data
Listed as ongoing, but also has a completion date and reported results 2007-003384-51 A Randomized, 4-Arm, Placebo-Controlled Phase 2 Trial of AMG 386 in Combination with Bevacizumab and Paclitaxel or AMG386 plus Paclitaxel as First-Line Therapy in Subjects with Her2-Negative, Metastat... 2014-05-19 bad-data
Ongoing, reported early 2007-003569-42 Estudio Aleatorizado, Doble Ciego, Controlado con Placebo, de Fase 1/2 para Determinar la Seguridad y la Eficacia de AMG 531 en Sujetos Pediátricos Trombocitopénicos con Púrpura Trombocitopénica Inmu... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2007-003573-50 A Randomized, Double Blind, Multi-Center, Phase 2 Study to Estimate the Efficacy and Evaluate the Safety and Tolerability of Cisplatin & Capecitabine (CX) in Combination with AMG 386 or Placebo in Sub... 2012-06-06 bad-data
Ongoing, reported early 2007-004722-25 A Phase 1b/2 Trial of AMG 655 in Combination with Panitumumab in Subjects with Metastatic Colorectal Cancer not-yet-due
Listed as ongoing, but also has a completion date and reported results 2007-005722-79 A Randomized, Open-Label, Controlled, Phase II Trial of Combination Chemotherapy with or without Panitumumab as First-line Treatment of Subjects with Metastatic or Recurrent Head and Neck Cancer, and ... 2014-03-06 bad-data
Listed as ongoing, but also has a completion date and reported results 2007-005792-34 A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Long-term Safety and Efficacy of Darbepoetin Alfa Administered at 500 μg Once-Every-3-Weeks in Anemic Subjects With Advanced S... 2018-06-05 bad-data
Listed as ongoing, but also has a completion date and reported results 2007-006050-25 An International, Randomized, Double-blind, Placebo-controlled, Phase 2 Study of AMG 479 with Exemestane or Fulvestrant in Postmenopausal Women with Hormone Receptor Positive Locally Advanced or Metas... 2011-08-15 bad-data
Listed as ongoing, but also has a completion date and reported results 2007-007258-75 A Randomized Double Blind, Placebo Controlled Study Evaluating the Efficacy and Safety of Romiplostim Treatment of Thrombocytopenia in Subjects with Low or Intermediate-1 Risk Myelodysplastic Syndrome... 2015-11-30 bad-data
Listed as ongoing, but also has a completion date and reported results 2008-001605-42 A Multicenter, Double-Blind, 3-Arm, Phase 1b/2 Study in Subjects with Unresectable Locally Advanced or Metastatic Gastric or Esophagogastric Junction Adenocarcinoma to Evaluate the Safety and Effica... 2013-06-19 bad-data
Listed as ongoing, but also has a completion date 2008-001606-16 An Open-label, Multi-center, Phase 2 Study of Denosumab in Subjects with Giant Cell Tumor of Bone 2018-05-17 bad-data
Completed, but no date 2008-001721-34 A Phase 2, Randomised, Double-blind, Placebo-controlled, Dose-finding Study of Darbepoetin alfa for the Treatment of Anemia in Paediatric Subjects with Solid Tumours Receiving Cyclic Chemotherapy bad-data
Listed as ongoing, but also has a completion date and reported results 2008-001751-21 A Randomized, Phase 1b/2 Trial of AMG 102 or AMG 479 in Combination with Panitumumab versus Panitumumab Alone in Subjects with Wild-Type KRAS Metastatic Colorectal Cancer 2013-10-31 bad-data
Reported results 2008-003258-14 A Phase 2, Randomized, Double-Blind, Placebo Controlled Study of AMG 386 in Combination with FOLFIRI in Subjects with Previously Treated Metastatic Colorectal Carcinoma 2012-05-16 due-trials
Listed as ongoing, but also has a completion date and reported results 2008-003292-42 A Phase 1b/ 2 Trial of AMG 479 or AMG 102 in Combination with Platinum-based Chemotherapy as First-Line Treatment for Extensive Stage Small Cell Lung Cancer 2013-02-28 bad-data
Listed as ongoing, but also has a completion date and reported results 2008-003418-88 A Multicenter, Double-blind, Randomized Study Evaluating De Novo Weekly and Once Every 2 Week Darbepoetin alfa Dosing for the Correction of Anemia in Pediatric Subjects With Chronic Kidney Disease Rec... 2014-03-03 bad-data
Reported results 2008-004281-71 A Randomized, Multicenter, Phase 2 Study to Compare the Efficacy of Panitumumab in Combination With mFOLFOX6 to the Efficacy of Bevacizumab in Combination With mFOLFOX6 in Patients With Previously U... 2016-07-16 due-trials
Listed as ongoing, but also has a completion date and reported results 2008-004347-10 A Prospective, Phase IV, Open-Label, Multi-Center Study Evaluating Changes in Bone Marrow Morphology in Adult Subjects Receiving Romiplostim for the Treatment of Thrombocytopenia Associated with Immun... 2014-01-09 bad-data
Listed as ongoing, but also has a completion date and reported results 2008-004355-30 A Phase 1b/2 Study to Assess the Safety and Efficacy of AMG 102 in Combination with Mitoxantrone and Prednisone in Subjects with Previously Treated Castrate Resistant Prostate Cancer 2012-04-30 bad-data
Ongoing 2008-004438-25 A Randomized, Double-Blind, Placebo Controlled, Phase 2 Trial of Paclitaxel in Combination With AMG 386 in Subjects With Advanced Recurrent Epithelial Ovarian or Primary Peritoneal Cancer not-yet-due
Listed as ongoing, but also has a completion date and reported results 2008-004558-34 Randomized Trial to Evaluate the Efficacy and Safety of Cinacalcet Treatment in Combination with Low Dose Vitamin D for the Treatment of Subjects with Secondary Hyperparathyroidism (SHPT) Recently Ini... 2011-07-05 bad-data
Listed as ongoing, but also has a completion date and reported results 2008-004752-77 A Phase 2 Study of Panitumumab Plus Irinotecan Followed by Panitumumab Plus AMG 479 in Subjects With Metastatic Colorectal Carcinoma Expressing Wild Type KRAS and Refractory to Oxaliplatin- or Irino... 2013-07-30 bad-data
Ongoing, reported early 2008-005074-12 A Phase 1b/2 Open Label, Dose Escalation Study of AMG 655 in Combination with AMG 479 in Subjects with Advanced, Refractory Solid Tumors. -------------------------------------------------------- Estud... not-yet-due
Listed as ongoing, but also has a completion date 2008-005140-16 Inhibición de la Delta-PROTEína cinasa C para la reducCCIÓN del tamaño del infarto en Infarto Agudo de Miocardio (PROTECCIÓN IAM) Inhibition of Delta-PROTEin kinase C for the reducTION of infarct size... 2011-06-17 bad-data
Listed as ongoing, but also has a completion date and reported results 2008-005301-19 A Phase 2, Randomized, Double-blind, Placebo-controlled Study Evaluating the Safety and Efficacy of FOLFIRI in Combination With AMG 479 or AMG 655 Versus FOLFIRI for the Second-line Treatment of KRAS-... 2012-06-04 bad-data
Listed as ongoing, but also has a completion date and reported results 2008-005991-28 A Randomized, Placebo-controlled, Multi-dose Phase 2 Study to Determine the Efficacy, Safety and Tolerability of AMG 785 in the Treatment of Postmenopausal Women with Low Bone Mineral Density 2016-02-03 bad-data
Reported results 2008-006154-17 An Open Label, Single Arm, Extension Study to Evaluate the Long Term Safety of Denosumab (AMG162) in the Treatment of Bone Loss in Subjects Undergoing Androgen-Deprivation Therapy for Non-metastatic P... 2012-05-13 due-trials
Ongoing 2008-006210-14 Phase 2 Open-Label Single-Arm, Multi-Center Study to Evaluate the Safety and Efficacy of Sunitinib Malate in Combination with AMG 386 as First Line or Second Line Therapy for Subjects with Metastatic ... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2008-006212-38 Phase 2, Open-label Single-Arm, Multi-Center Study to Evaluate the Efficacy and Safety of AMG 386 and Sorafenib as First Line Therapy for Subjects with Advanced or Inoperable Hepatocellular Carcinoma. 2015-06-21 bad-data
Listed as ongoing, but also has a completion date and reported results 2008-008392-34 A Multi-center, Randomized, Double-blind, Placebo-controlled Study of AMG 785 in Skeletally Mature Adults with a Fresh Unilateral Tibial Diaphyseal Fracture Status Post Definitive Fracture Fixation wi... 2013-07-11 bad-data
Listed as ongoing, but also has a completion date and reported results 2009-009374-27 An Open Label, Single Arm, Extension Study to Evaluate the Long Term Safety of Denosumab in the Treatment of Bone Metastases in Subjects with Advanced Cancer or Multiple Myeloma 2012-04-28 bad-data
Listed as ongoing, but also has a completion date and reported results 2009-009756-21 A Single-arm, Multicenter, Proof-of-concept Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects with Elevated Serum Calcium Despite Recent Treatment with IV Bisphosphonate... 2013-08-21 bad-data
Listed as ongoing, but also has a completion date and reported results 2009-010205-37 A Multicenter, Randomized, Double-Blind, Placebo Controlled Study to Compare the Efficacy and Safety of Denosumab versus Placebo in Males with Low Bone Mineral Density 2012-05-15 bad-data
Listed as ongoing, but also has a completion date and reported results 2009-010587-42 A Randomized Open-Label Study to Evaluate the Safety and Efficacy of Denosumab and Monthly Actonel Therapies in Postmenopausal Women Transitioned from Weekly or Daily Alendronate Therapy. 2011-12-21 bad-data
Listed as ongoing, but also has a completion date and reported results 2009-010715-32 A Randomized, Multicenter, Open-label, Phase 3 Study to Compare the Efficacy and Safety of Panitumumab and Cetuximab in Subjects with Previously Treated, Wild-type KRAS, Metastatic Colorectal Cancer 2017-07-22 bad-data
Ongoing, reported early 2009-010726-19 A Randomized Open-Label Study to Evaluate the Safety and Efficacy of Denosumab and Ibandronate in Postmenopausal Women Sub-Optimally Treated with Daily or Weekly Bisphosphonates. not-yet-due
Listed as ongoing, but also has a completion date 2009-011299-32 A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Phase 3 Study of Denosumab as Adjuvant Treatment for Women with Early-Stage Breast Cancer at High Risk of Recurrence 2018-03-26 bad-data
Listed as ongoing, but also has a completion date and reported results 2009-011899-30 A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Pegfilgrastim Administered to Subjects With Newly Diagnosed, Locally-advanced or Metastatic Colorectal Cancer Treated With Bevacizuma... 2015-01-02 bad-data
Reported results 2009-012076-26 A Double-blind, Placebo-controlled Study to Evaluate New or Worsening Lens Opacifications in Subjects with Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss due to Androgen-Deprivation ... 2016-05-12 due-trials
Listed as ongoing, but also has a completion date and reported results 2009-012566-32 A Randomized, Double-blind, Placebo-controlled, Multiple-dose Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 827 in Subjects with Rheumatoid Arthritis and an Inadequate Response to Me... 2011-02-11 bad-data
Reported results 2009-012943-41 A Randomized Double-blind Placebo-controlled Study to Evaluate the Efficacy and Safety of Cinacalcet for the Treatment of Hypercalcemia in Subjects With Primary Hyperparathyroidism Unable to Undergo P... 2012-12-21 due-trials
Listed as ongoing, but also has a completion date and reported results 2009-013538-26 A Randomized, Double-Blind, Placebo Controlled, Multiple Dose Phase 2 Study to Determine the Safety and Efficacy of AMG 853 in Subjects with Inadequately Controlled Asthma 2010-12-13 bad-data
Listed as ongoing, but also has a completion date and reported results 2009-013539-39 A Randomized, Double-blind, Placebo-controlled, Multiple-dose Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 827 in Subjects with Psoriasis 2010-09-27 bad-data
Listed as ongoing, but also has a completion date and reported results 2009-015939-33 A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Determine the Efficacy, Safety, and Tolerability of AMG 785 in Adults with a Fresh Unilateral Hip Fracture, Status Post Surgical F... 2013-05-20 bad-data
Completed, but no date, and reported results 2009-015989-62 An Open Label, Multicenter, Exploratory Phase II Study to Evaluate the Efficacy, Safety, and Tolerability of the BiTE Antibody Blinatumomab in Adult Patients with Relapsed/Refractory B-Precursor Acute... bad-data
Reported results 2009-016119-38 A Long-term Assessment of the Safety and Efficacy of AMG 827 Subcutaneous Treatment in Subjects with Rheumatoid Arthritis. 2011-04-06 due-trials
Completed, but no date, and reported results 2009-016163-12 A Long-term Assessment of the Safety and Efficacy of AMG 827 Subcutaneous Treatment in Subjects with Psoriasis. bad-data
Listed as ongoing, but also has a completion date and reported results 2009-016203-32 An Open Label Study Evaluating the Safety and Efficacy of Long-Term Dosing of Romiplostim in Thrombocytopenic Pediatric Subjects With Immune (Idiopathic) Thrombocytopenia Purpura (ITP) 2017-01-12 bad-data
Listed as ongoing, but also has a completion date and reported results 2009-016522-14 A Multicenter, Randomised, Double-blind, Placebo-controlled Study of Darbepoetin alfa for the Treatment of Anaemic Subjects with 2017-09-22 bad-data
Listed as ongoing, but also has a completion date and reported results 2009-017946-30 A Phase 3, Randomized, Double-Blind Trial of Pegylated Liposomal Doxorubicin (PLD) Plus AMG 386 or Placebo in Women With Recurrent Partially Platinum Sensitive or Resistant Epithelial Ovarian, Primary... 2017-04-19 bad-data
Listed as ongoing, but also has a completion date and reported results 2009-017999-25 An Open-Label, Single-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Cinacalcet HCl in Pediatric Subjects Aged 28 Days to < 6 Years with Chronic Kidney Disea... 2015-09-23 bad-data
Ongoing 2010-018314-75 A confirmatory multicenter, single-arm study to assess the efficacy, safety, and tolerability of the BiTE antibody blinatumomab in adult patients with minimal residual disease (MRD) of B-precursor acu... not-yet-due
No trial status on register 2010-018426-39 A Phase 3 Randomized, Double Blind, Placebo Controlled Study to Determine the Safety and Efficacy of Romiplostim in Thrombocytopenic Pediatric Subjects with Immune Thrombocytopenia (ITP) bad-data
Reported results 2010-019543-19 A Randomized, Double-blind, Placebo-controlled Phase 2 Study to Determine the Safety and Efficacy of AMG 827 in Subjects wth Inadequately Controlled Asthma 2011-12-21 due-trials
Ongoing, reported early 2010-019544-39 A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 827 in Subjects with Moderate to Severe Crohn’s Disease not-yet-due
Listed as ongoing, but also has a completion date and reported results 2010-019821-32 A Phase 3, Randomized, Double-Blind Trial of Weekly Paclitaxel Plus AMG 386 or Placebo in Women With Recurrent Partially Platinum Sensitive or Resistant Epithelial Ovarian, Primary Peritoneal or Fal... 2016-12-16 bad-data
Listed as ongoing, but also has a completion date and reported results 2010-019987-35 A Phase 2, Interventional, Single Arm Study Describing Platelet Responses and ITP Remission Rates in Adult Subjects with Immune Thrombocytopenia Purpura Receiving Romiplostim. 2013-12-26 bad-data
Listed as ongoing, but also has a completion date and reported results 2010-020398-18 A Phase 3, Multicenter, Randomized, Double-Blind, Placebo Controlled Trial of AMG 479 or Placebo in Combination with Gemcitabine as First-line Therapy for Metastatic Adenocarcinoma 2012-12-12 bad-data
Ongoing 2010-020454-34 A Randomized, Double-Blind, Multicenter Study of Denosumab Compared With Zoledronic Acid in the Treatment of Bone Disease in Subjects with Newly Diagnosed Multiple Myeloma not-yet-due
Completed, but no date, and reported results 2010-020881-53 A Long-term Assessment of Safety and Efficacy of AMG 827 Treatment in Subjects With Crohn’s Disease bad-data
Listed as ongoing, but also has a completion date and reported results 2010-021003-24 A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Safety and Efficacy of IV Infusion Treatment With Omecamtiv Mecarbil in Subjects With Left Ventricular Systolic Dysfun... 2013-04-18 bad-data
Listed as ongoing, but also has a completion date and reported results 2010-021846-23 An Open Label, Single Arm, Extension Study to Evaluate the Long Term Safety of Denosumab for Prolonging Bone Metastasis-Free Survival in Men with Hormone-Refractory Prostate Cancer 2014-02-21 bad-data
Ongoing 2010-022270-14 Estudio abierto de extensión de fase 2 con conatumumab . A Phase 2 Open Label Extension Study of Conatumumab. not-yet-due
Reported results 2010-022951-49 A Phase 3, Multicenter, Randomized, Open-label Trial to Evaluate the Survival Benefit of Panitumumab and Best Supportive Care, Compared to Best Supportive Care Alone, in Subjects With Chemorefractory ... 2016-11-08 due-trials
Listed as ongoing, but also has a completion date and reported results 2010-023150-37 A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Cinacalcet HCl in Pediatric Subjects with Chronic Kidney Disease and Secondary Hyperparathyroidism Receiving D... 2014-02-14 bad-data
Listed as ongoing, but also has a completion date and reported results 2010-023978-39 A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Trial of AMG 479 or Placebo in Combination with Gemcitabine as First-line Therapy for Locally Advanced Unresectable Adenocarcinoma... 2012-12-12 bad-data
Listed as ongoing, but also has a completion date and reported results 2010-024264-18 A Single-Arm Multicenter Phase II Study preceded by Dose Evaluation to Investigate the Efficacy, Safety, and Tolerability of the BiTE® Antibody Blinatumomab (MT103) in Pediatric and Adolescent Patient... 2016-06-20 bad-data
Reported results 2010-024393-19 A Randomized, Double-blind, Active-controlled Study to Evaluate the Efficacy and Safety of Denosumab Compared With Risedronate in Glucocorticoid-treated Individuals 2017-06-29 due-trials
Reported results 2011-001111-31 A Phase 1b/2 Trial of AMG 386 in Combination With Pemetrexed and 2015-11-18 due-trials
Reported results 2011-001112-53 A Phase 3 Randomized, Double-blind, Placebo-controlled, Multicenter Study of AMG 386 With Paclitaxel and Carboplatin as First-line Treatment of Subjects With FIGO Stage III-IV Epithelial Ovarian, Prim... 2016-12-05 due-trials
Listed as ongoing, but also has a completion date and reported results 2011-001456-11 A Multicenter, International, Randomized, Double-blind, Placebo controlled, Parallel-group Study to Assess the Efficacy and Safety of AMG 785 Treatment in Postmenopausal Women With Osteoporosis 2016-12-28 bad-data
Reported results 2011-001527-20 TIMI 57 - A Double-Blind, Randomized, Placebo-controlled, Multicenter, Dose-ranging Study to Evaluate Tolerability and Efficacy of AMG 145 on LDL-C in Combination with HMG-CoA Reductase Inhibitors in ... 2012-04-05 due-trials
Reported results 2011-001528-39 "A Double-blind, Radomized, Placebo-comtrolled, Multicenter Study to Evaluate Tolerability and Efficacy of AMG 145 on LDL-C in Subjects with Heterozygous Familial Hypercholesterolemia" 2012-05-16 due-trials
Reported results 2011-001529-26 A Randomized, Multicenter Study to Evaluate Tolerability and Efficacy of AMG 145 on LDL-C, Compared with Ezetimibe, in Hypercholesterolemic Subjects Unable to Tolerate an Effective Dose of a HMG-CoA R... 2012-05-08 due-trials
Reported results 2011-001544-30 A Randomized, Placebo and Ezetimibe Controlled, Dose-ranging Study to Evaluate Tolerability and Efficacy of AMG 145 on LDL-C in Hypercholesterolemic Subjects With a 10 Year Framingham Risk Score of 10... 2012-03-02 due-trials
Listed as ongoing, but also has a completion date 2011-001915-29 A Multicenter, Controlled, Open-Label Extension (OLE) Study To Assess the Long-Term Safety and Efficacy of AMG 145 2018-06-20 bad-data
Listed as ongoing, but also has a completion date 2011-002114-36 Open-Label Access Protocol of Denosumab for Subjects with Advanced Cancer 2013-10-02 bad-data
Ongoing 2011-002150-31 An Open-label, Single-dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Darbepoetin alfa in Paediatric Subjects From Birth to Less than 1 Year of Age With Anem... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2011-002257-61 An open label, multicenter, phase II study to evaluate efficacy and safety of the BiTE antibody blinatumomab in adult patients with relapsed/refractory B-precursor acute lymphoblastic leukemia (ALL) 2017-01-03 bad-data
Listed as ongoing, but also has a completion date and reported results 2011-003142-41 A Multicenter, International, Randomized, Double-blind, 2018-02-28 bad-data
Reported results 2011-003827-37 A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate Long-term Tolerability and Durable Efficacy of AMG 145 on LDL-C in Hyperlipidemic Subjects 2013-10-14 due-trials
Listed as ongoing, but also has a completion date and reported results 2011-004618-40 An Open-label, Single-arm Study to Assess the Safety and Tolerability of Cinacalcet HCl in Addition to Standard of Care in Pediatric Subjects Age 28 Days to < 6 Years with Chronic Kidney Disease and S... 2016-06-04 bad-data
Other 2011-004844-23 A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Add-on AMG 747 on Schizophrenia Negative Symptoms (Study 299) not-yet-due
Reported results 2011-004845-42 A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Add-on AMG 747 on Schizophrenia Negative Symptoms (Study 165) 2013-05-20 due-trials
Listed as ongoing, but also has a completion date and reported results 2011-004923-11 A Phase 3, Multicenter, Randomized, Double-Blind, Placebo Controlled Study of Rilotumumab (AMG 102) with Epirubicin, Cisplatin, and Capecitabine (ECX) as First-line Therapy in Advanced MET-Positive Ga... 2015-09-10 bad-data
Other 2011-005019-96 A Single Arm, Open-label, Long-term Efficacy and Safety Study of Romiplostim in Thrombocytopenic Pediatric Subjects With Immune Thrombocytopenia (ITP) not-yet-due
Listed as ongoing, but also has a completion date 2011-005251-13 A Randomized, Double blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects with Moderate to Severe Ulcerative Colitis 2018-04-10 bad-data
Listed as ongoing, but also has a completion date and reported results 2011-005399-40 A two part, Phase 2/3 Study to Assess the Safety, Tolerability and Efficacy of AMG 145 in Subjects With Homozygous Familial Hypercholesterolemia 2014-01-31 bad-data
Listed as ongoing, but also has a completion date 2011-005400-15 A Multicenter, Open-label Study to Assess the Long-term Safety, Tolerability, and Efficacy of AMG 145 on LDL-C in Subjects With Severe Familial Hypercholesterolemia 2018-05-11 bad-data
Reported results 2011-005781-38 An Open Label, Multicenter, Exploratory Phase 2 Study to Evaluate the Efficacy and Safety of the Bispecific T-Cell Engager (BiTE) Blinatumomab in Patients with Relapsed/Refractory Diffuse Large B-Cell... 2015-09-09 due-trials
Ongoing 2012-000307-32 A Phase 1b/2, Multicenter, Open-label Trial to Evaluate the Safety and Efficacy of Talimogene Laherparepvec and Ipilimumab Compared to Ipilimumab Alone in Subjects With Unresected, Stage IIIB-IV Melan... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2012-000327-40 A Double-blind, Randomized, Placebo-controlled, Multicenter, Dose 2015-08-19 bad-data
Listed as ongoing, but also has a completion date 2012-000529-31 A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects with Moderate to Severe Crohn’s Disease 2018-04-10 bad-data
Reported results 2012-000651-13 A Phase 3 Study to Evaluate the Efficacy, Safety, and Effect of Withdrawal and Retreatment With Brodalumab in Subjects With Moderate to Severe Plaque 2015-10-02 due-trials
Reported results 2012-000656-34 A Phase 3 Study to Evaluate the Efficacy and Safety of Induction and Maintenance Regimens of Brodalumab Compared With Placebo and Ustekinumab in Subjects With Moderate to Severe Plaque Psoriasis: AMAG... 2016-10-16 due-trials
Reported results 2012-000667-24 A Phase 3 Study to Evaluate the Efficacy and Safety of Induction and Maintenance Regimens of Brodalumab Compared With Placebo and Ustekinumab in Subjects With Moderate to Severe Plaque Psoriasis: AMAG... 2016-10-20 due-trials
No trial status on register 2012-001145-40 Open-label Extension Treatment with TNFR:Fc for Participating Patients in TNFR:Fc Clinical Trials bad-data
No trial status on register 2012-001171-37 A Phase IV Registry of Etanercept in Children With Juvenile Rheumatoid Arthritis bad-data
No trial status on register 2012-001186-33 An Open-Label Extension Study to Evaluate the Safety of Etanercept in Pediatric Subjects With Plaque Psoriasis bad-data
Reported results 2012-001362-15 A Double-blind, Randomized, Placebo and Ezetimibe-controlled, Multicenter Study to Evaluate Safety and Efficacy of Lipid Lowering Monotherapy With AMG 145 in Subjects With a 10-Year Framingham Risk Sc... 2013-10-29 due-trials
Listed as ongoing, but also has a completion date and reported results 2012-001363-70 A Double-blind, Randomized, Placebo and Ezetimibe Controlled, Multicenter Study to Evaluate Safety, Tolerability and Efficacy of AMG 145 on LDL-C in Combination With Statin Therapy in Subjects With Pr... 2013-12-04 bad-data
Listed as ongoing, but also has a completion date and reported results 2012-001364-30 A Double-blind, Randomized, Multicenter Study to Evaluate Safety and Efficacy of AMG 145, Compared With Ezetimibe, in Hypercholesterolemic Subjects Unable to Tolerate an Effective Dose of a HMG-CoA Re... 2013-11-19 bad-data
Listed as ongoing, but also has a completion date and reported results 2012-001365-32 A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate Safety, Tolerability and Efficacy of AMG 145 on LDL-C in Subjects with Heterozygous Familial Hypercholesterolemia 2013-12-11 bad-data
Reported results 2012-001382-32 A Randomized, Double-Blind, Placebo-Controlled Study to Explore Dose Effect and Frequency of Administration of AMG 151 in Subjects with Type 2 Diabetes Mellitus 2012-10-19 due-trials
Listed as ongoing, but also has a completion date and reported results 2012-001398-97 A Double-blind, Randomized, Placebo-controlled, Multicenter Study Assessing the Impact of Additional LDL-Cholesterol Reduction on Major Cardiovascular Events When AMG 145 is Used in Combination With S... 2016-11-11 bad-data
Reported results 2012-001821-28 A Randomized Double-blind Study to Evaluate the Safety and Efficacy of Denosumab Compared With Zoledronic Acid in Postmenopausal Women With Osteoporosis Previously Treated With Oral Bisphosphonates 2015-01-07 due-trials
Listed as ongoing, but also has a completion date and reported results 2012-002805-23 A Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Assess the Efficacy and Safety of AMG 416 in the Treatment of Secondary Hyperparathyroidism in Subjects With Chronic Kidney Disease on ... 2014-06-12 bad-data
Reported results 2012-002806-31 A Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Assess the Efficacy and Safety of AMG 416 in the Treatment of Secondary Hyperparathyroidism in Subjects With Chronic Kidney Disease on ... 2014-05-09 due-trials
Listed as ongoing, but also has a completion date and reported results 2012-002808-41 A Multicenter Single-arm Extension Study to Describe the Long-term Efficacy and Safety of AMG 416 in the Treatment of Secondary 2016-07-15 bad-data
Reported results 2012-002948-24 An Open-label, Randomized, Teriparatide-controlled Study to Evaluate the Effect of Treatment with AMG 785 in Postmenopausal Women with Osteoporosis Previously Treated with Bisphosphonate Therapy 2015-05-15 due-trials
Reported results 2012-003351-11 A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Brodalumab in Subjects With Inadequately Controlled Asthma and High Bronchodilator Reversibility 2015-05-01 due-trials
Listed as ongoing, but also has a completion date and reported results 2012-004208-37 A Double-Blind, Randomized, Multi-Center, Placebo-Controlled, Parallel Group Study to Determine the Effects of Evolocumab (AMG-145) Treatment on Atherosclerotic Disease Burden As Measured By Intravasc... 2016-07-29 bad-data
Listed as ongoing, but also has a completion date and reported results 2012-004319-29 A Randomized, Double-Blind, Phase 3 Study Evaluating the Efficacy and Safety of ABP 980 Compared with Trastuzumab in Subjects with HER2 Positive Early Breast Cancer 2017-01-27 bad-data
Listed as ongoing, but also has a completion date 2012-004357-83 A Multicenter, Controlled, Open-label Extension (OLE) Study to Assess the Long-term Safety and Efficacy of AMG 145 2018-05-18 bad-data
Ongoing 2012-005331-90 A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of AMG 334 in Migraine Prevention not-yet-due
Reported results 2013-000192-33 A Multicenter, Multiple-dose, Two-arm, Active-controlled, Double-blind, Double-dummy Study to Compare the Therapeutic Efficacy and Safety of Oral Doses of Cinacalcet HCl With Intravenous Doses of AMG ... 2014-12-24 due-trials
Reported results 2013-000434-35 A Multicenter, Randomized, Multiple-dose Phase 3 Study to Evaluate the 2015-01-08 due-trials
Reported results 2013-000525-31 A Randomized, Double-blind, Phase 3 Study of ABP 501 Efficacy and Safety Compared to Adalimumab in Subjects with Moderate to Severe Rheumatoid Arthritis 2014-11-19 due-trials
Listed as ongoing, but also has a completion date and reported results 2013-000536-10 A Phase 3, Randomized, Open Label Study Investigating the Efficacy of the BiTE® Antibody Blinatumomab Versus Standard of Care Chemotherapy in Adult Subjects With Relapsed/Refractory B-precursor Acute ... 2017-03-14 bad-data
Listed as ongoing, but also has a completion date and reported results 2013-000537-12 A Phase 3, Multicenter, randomized, double-blind study evaluating the efficacy and safety of ABP 501 compared with Adalimumab in subjects with moderate to severe plaque psoriasis 2015-03-18 bad-data
Listed as ongoing, but also has a completion date and reported results 2013-000706-36 A Phase 2 Single Arm, Multicenter Trial to Evaluate the Efficacy of the BiTE® Antibody Blinatumomab in Adult Subjects with Relapsed/Refractory Philadelphia Positive B-precursor Acute Lymphoblastic Leu... 2017-01-06 bad-data
Completed, report not yet due 2013-000723-14 A Double-blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate Safety and Efficacy of Evolocumab (AMG 145) in Combination With Statin Therapy in Diabetic Subjects With Hyperlipidemia or... 2017-12-06 not-yet-due
Completed, but no date, and reported results 2013-000727-13 Single arm, Companion Study to Myelodysplastic Syndrome (MDS) bad-data
Reported results 2013-000738-36 A Randomized, Double-Blind, Phase 3 Study Evaluating the Efficacy and Safety OF ABP 215 Compared with Bevacizumab in Subjects with Advanced Non-Small Cell Lung Cancer 2015-07-23 due-trials
Listed as ongoing, but also has a completion date 2013-000935-29 A Double-blind, Randomized, Multicenter Study to Evaluate the Safety and Efficacy of AMG 145, Compared With Ezetimibe, in Hypercholesterolemic Subjects Unable to Tolerate an Effective Dose of a HMG-Co... 2017-11-21 bad-data
Listed as ongoing, but also has a completion date and reported results 2013-001277-24 A Multicenter, Phase 2, Single Arm, Two Cohort Study Evaluating the Efficacy, Safety, and Pharmacokinetics of AMG 337 in Subjects with MET Amplified Gastric/Gastroesophageal Junction/Esophageal Adenoc... 2016-10-10 bad-data
Reported results 2013-001279-19 A Multicenter, Double-blind, Randomized Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis 2015-07-09 due-trials
Listed as ongoing, but also has a completion date 2013-001662-42 A Randomized, Double-blind, Multi-center Phase 2 Trial of Denosumab in Combination With Chemotherapy as First-line Treatment of Metastatic Non-small Cell Lung Cancer 2017-11-28 bad-data
Reported results 2013-001707-36 A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of AMG 334 in Chronic Migraine Prevention 2016-07-06 due-trials
Reported results 2013-003553-16 A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy and Safety of Brodalumab in Subjects with Psoriatic Arthritis: AMVISION-2 2015-10-01 due-trials
Listed as ongoing, but also has a completion date and reported results 2013-003554-25 A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy, Safety and Effect on Radiographic Progression of Brodalumab in Subjects with Psoriatic Arthritis: AMVISION-1 2015-10-22 bad-data
Listed as ongoing, but also has a completion date and reported results 2013-004136-30 A Multicenter Single-arm Extension Study to Describe the Long-term Safety of AMG 416 in the Treatment of Secondary Hyperparathyroidism in Subjects With Chronic Kidney Disease on Hemodialysis 2017-09-28 bad-data
Listed as ongoing, but also has a completion date and reported results 2013-004654-13 An Open-Label, Single-arm Extension Study to Evaluate the Long-term Safety and Efficacy of ABP 501 in Subjects with Moderate to Severe Rheumatoid Arthritis 2016-04-11 bad-data
Listed as ongoing, but also has a completion date and reported results 2013-004958-18 A Randomized, Open-label, Controlled Study to Assess the Efficacy and 2016-06-23 bad-data
Listed as ongoing, but also has a completion date and reported results 2013-005311-27 An Open-label Extension (OLE) Study to Assess the Long-term Safety and Efficacy of AMG 334 2017-05-26 bad-data
Ongoing 2013-005542-11 A Randomized, Double-Blind Study Evaluating the Efficacy, Safety and Immunogenicity of ABP 798 Compared with Rituximab in Subjects with CD20 Positive B-Cell Non-Hodgkin Lymphoma (NHL) not-yet-due
Ongoing 2013-005543-90 A Randomized, Double-Blind Study to Compare Pharmacokinetics and Pharmacodynamics, Efficacy and Safety of ABP 798 With Rituximab in Subjects With Moderate to Severe Rheumatoid Arthritis not-yet-due
Reported results 2013-005551-32 A Multicenter, Randomized, Double blind, Placebo controlled Study to Compare the Efficacy and Safety of Romosozumab With Placebo in Men With Osteoporosis 2016-04-20 due-trials
Ongoing 2013-005552-15 A Phase 2, Multicenter, Open-label, Single-arm Trial to Evaluate the Correlation Between Objective Response Rate and Baseline Immunoprofile Intratumoral CD8+ Cell Density in Subjects With Unresected S... not-yet-due
Listed as ongoing, but also has a completion date 2014-000184-40 Prospective, Multicenter, Single-arm Study to Evaluate Efficacy, Safety, and Pharmacokinetics of Denosumab in Children With Osteogenesis Imperfecta 2015-10-22 bad-data
Ongoing 2014-000185-22 A Phase 1b/2, Multicenter, Open-label Trial of Talimogene Laherparepvec in Combination With MK-3475 for Treatment of Previously Untreated, Unresected, Stage IIIB to IVM1c Melanoma not-yet-due
Ongoing 2014-001146-13 A Phase 2, Multicenter, Randomized, Open-label Trial Assessing the Efficacy and Safety of Talimogene Laherparepvec Neoadjuvant Treatment Plus Surgery Versus Surgery Alone for Resectable, Stage IIIB to... not-yet-due
Listed as ongoing, but also has a completion date 2014-001524-30 A Multicenter, Open-label Extension (OLE) Study to Assess the Long-term Safety and Efficacy of Evolocumab 2018-03-09 bad-data
Ongoing 2014-001700-21 An Open-Label, Multi-center, Expanded Access Protocol of Blinatumomab for the Treatment of Pediatric and Adolescent Subjects with Relapsed and/or Refractory B-precursor Acute Lymphoblastic Leukemia (A... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2014-001976-75 A Double-Blind, Placebo Controlled, Multicenter Study to Assess the Effect of Evolocumab on Cognitive Function in Patients with Clinically Evident Cardiovascular Disease and Receiving Statin Backgroun... 2016-11-11 bad-data
Other 2014-002277-11 Double-blind, Randomized, Multicenter, Placebo-Controlled, Parallel Group Study to Characterize the Efficacy, Safety, and Tolerability of 24 Weeks of Evolocumab for Low Density Lipoprotein-Cholesterol... not-yet-due
Other 2014-002476-92 A Randomized, Open-label, Controlled Phase 3 Adaptive Trial to Investigate the Efficacy, Safety, and Tolerability of the BiTE® Antibody Blinatumomab as Consolidation Therapy Versus Conventional Consol... not-yet-due
Completed, but no date, and reported results 2014-002834-30 A Phase 3b, Multicenter, Open-label, Single-arm, Expanded Access Protocol bad-data
Listed as ongoing, but also has a completion date and reported results 2014-003563-38 A Multicenter Single-arm Extension Study to Characterize the Long-term Safety of Cinacalcet Hydrochloride in the Treatment of Secondary Hyperparathyroidism in Pediatric Subjects With Chronic Kidney Di... 2017-03-15 bad-data
Not reported 2014-003701-15 A Randomized, Double-blind, Placebo-controlled Study With an Open Label Extension to Evaluate the Safety and Efficacy of Brodalumab in Subjects With Axial Spondyloarthritis 2015-05-28 due-trials
Reported results 2014-004463-20 A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of AMG 334 in Migraine Prevention 2017-03-20 due-trials
Reported results 2014-004464-38 A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of AMG 334 in Migraine Prevention 2017-06-19 due-trials
Completed, report not yet due 2014-004704-29 A Randomized, Double-Blind Phase 3 Study to Assess the Efficacy and Safety of ABP 710 Compared to Infliximab in Subjects with Moderate to Severe Rheumatoid Arthritis 2018-08-13 not-yet-due
Ongoing 2014-004868-38 A Randomized Withdrawal Double-blind Study of Etanercept Monotherapy Compared to Methotrexate Monotherapy for Maintenance of Remission in Subjects With Rheumatoid Arthritis. not-yet-due
Listed as ongoing, but also has a completion date 2014-004869-24 A Multicenter Double-Blind, Randomized Controlled Study of Etanercept and Methotrexate in Combination or as Monotherapy in Subjects With Psoriatic Arthritis. 2018-07-06 bad-data
No trial status on register 2014-005034-66 An Open-label, Randomized, Single-dose, 3-period, 3-treatment Crossover Study to Assess the Comparative Bioavailability of 5mg Cinacalcet Capsules to the 30mg Commercial Formulation Cinacalcet Tablets... bad-data
No trial status on register 2014-005190-36 A Phase 1 Study to Evaluate the Safety and Pharmacokinetics of Panitumumab in Children with Solid Tumors bad-data
Ongoing 2014-005386-67 A Phase 1b/2, Multicenter, Open-label Trial to Evaluate the Safety of Talimogene Laherparepvec Injected into Liver Tumors Alone and in Combination With Systemic Pembrolizumab not-yet-due
Reported results 2015-001343-37 A Randomized, Actively Controlled, Open-label, Multicenter Study of Efficacy and Safety of Evolocumab Compared With Low Density Lipoprotein Cholesterol (LDL-C) Apheresis, Followed by Single-Arm Evoloc... 2017-01-20 due-trials
Ongoing 2015-002276-25 Open-label, Single-arm, Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of Evolocumab for LDL-C Reduction, as Add-on to Diet and Lipid-lowering Therapy, in Pediatric Subjects From ... not-yet-due
Reported results 2015-002322-40 A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of AMG 334 on Exercise Time During a Treadmill Test in Subjects With Stable Angina 2017-04-13 due-trials
No trial status on register 2015-002466-22 A Randomized, Multi-center, Blinded, Placebo-controlled Study With an Open­label Run-in Period to Evaluate the Efficacy, Safety, and Pharmacokinetics of Daily, Single, Subcutaneous Injections of r-met... bad-data
Ongoing 2015-003011-38 A Phase 1b/3 Multicenter, Randomized, Open-label Trial of Talimogene Laherparepvec in combination with Pembrolizumab for theTreatment of Subjects With Recurrent or Metastatic Squamous Cell Carcinoma o... not-yet-due
Ongoing 2015-003196-29 A Registry Study to Evaluate the Survival and Long-Term Safety of Subjects Who Previously Received Talimogene Laherparepvec in Amgen or BioVEX-Sponsored Clinical Trials not-yet-due
Ongoing 2015-003645-25 A Phase 1, Multi-center, Open-label, Dose De-escalation Study to Evaluate the Safety and Efficacy of Talimogene Laherparepvec in Pediatric Subjects with Advanced Non Central Nervous SystemTumors That ... not-yet-due
Completed, report not yet due 2015-003731-35 A Randomized Double-blind Placebo Controlled Study Characterizing The Effects of PCSK9 Inhibition On Arterial Wall inflammation in Patients With Elevated Lp(a) 2018-04-05 not-yet-due
Reported results 2015-004711-21 A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate Safety, Tolerability, and Efficacy of Evolocumab (AMG 145) on LDL-C in Subjects With Type 2 Diabetes Mellitus and Hypercho... 2017-09-05 due-trials
Ongoing 2015-004735-12 A Double Blind, Randomized, Placebo Controlled, Multicenter Study toEvaluate Safety, Tolerability, and Efficacy on LDL-C of Evolocumab (AMG 145) in Subjects with HIV and with Hyperlipidemia and/or Mix... not-yet-due
Ongoing 2015-004780-36 A Multicenter, Open-label, Single-arm, Extension Study to Assess Long-term Safety of Evolocumab Therapy in Patients With Clinically Evident Cardiovascular Disease not-yet-due
Ongoing 2015-005051-28 An Open-label, Single-dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Etelcalcetide (AMG 416) in Paediatric Subjects Aged 2 to less than 18 Years with Second... not-yet-due
Ongoing 2016-001080-36 A Phase 1b/2 Study Assessing Safety and Anti-tumor Activity of AMG 820 in Combination With Pembrolizumab in Select Advanced Solid Tumors not-yet-due
Ongoing 2016-002044-16 A Phase 2/3 Multi-center Study of Evaluate the Safety and Efficacy of Blinatumomab in Subjects with Relapsed/Refractory Aggressive B-Cell Non Hodgkin Lymphoma not-yet-due
Ongoing 2016-002190-35 A Phase 2 Open-label Study Investigating the Safety and Efficacy of Blinatumomab After Frontline R-Chemotherapy in Adult Subjects With Newly Diagnosed High-risk Diffuse Large B-Cell Lymphoma (DLBCL) not-yet-due
Ongoing 2016-002299-28 A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Omecamtiv Mecarbil on Mortality and Morbidity in Subjects With Chronic Heart Failure With Reduced... not-yet-due
Other 2016-003083-39 A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Safety and Efficacy of Denosumab in Pediatric Subjects With Glucocorticoid-induced Osteoporosis not-yet-due
Ongoing 2016-003255-30 A Phase 2 Open-Label Study to Determine the Effect of Blinatumomab on Minimal Residual Disease in Subjects With High-risk Diffuse Large B-Cell Lymphoma Post-autologous Hematopoietic Stem-cell Transpla... not-yet-due
Ongoing 2016-003554-33 A Randomized, Open-label, Phase 3 Study Comparing Carfilzomib, Dexamethasone, and Daratumumab to Carfilzomib and Dexamethasone for the treatment of Patients With Relapsed or Refractory Multiple Myelom... not-yet-due
Ongoing 2016-004066-26 A Multicenter, Open-label, Single-arm, Extension Study to Assess Long-term Safety of Evolocumab Therapy in Subjects With Clinically Evident Cardiovascular Disease in Selected European Countries not-yet-due
Ongoing 2017-000630-57 A Phase 2a Randomized Double-blind Placebo Controlled Study to Evaluate the Efficacy and Safety of AMG 301 in Migraine Prevention. not-yet-due
Not reported 2017-000675-90 A Phase 3b, Multicenter, Randomized, Double-blind, Parallel Group, Alendronate-Controlled Study in Postmenopausal Women with Osteoporosis Previously Treated with Romosozumab Followed by Alendronate Se... 2017-05-29 due-trials
Ongoing 2017-000763-33 A Phase 1b/2 Open-label Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of AMG 592 in Adult Subjects with Steroid Refractory Chronic Graft versus Host Diseas... not-yet-due
Ongoing 2017-001418-27 A RANDOMIZED, DOUBLE-BLIND, ACTIVE-CONTROLLED PHASE 3 STUDY EVALUATING THE EFFICACY AND SAFETY OF ABP 959 COMPARED WITH ECULIZUMAB IN ADULT SUBJECTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) not-yet-due
Other 2017-001758-32 Long-term Safety Follow-up of Subjects With Giant Cell Tumour of Bone Treated With Denosumab in Study 20062004 not-yet-due
Ongoing 2017-001944-36 A Phase 1b/2a Study to Evaluate the Safety and Efficacy of AMG 592 in Subjects with Active Rheumatoid Arthritis With Inadequate Response to Standard of Care Therapy not-yet-due
Ongoing 2017-002564-40 A Phase 1b/2a Study to Evaluate the Safety and Efficacy of AMG 592 in Subjects With Active Systemic Lupus Erythematosus With Inadequate Response to Standard of Care Therapy. not-yet-due
No trial status on register 2017-002659-28 An open-label, Randomized, Single-dose, 2-Period, "-Treatment Crossover Study to Assess the Bioequivalence of Cinacalcet Capsule (Administered as Six of the 5 mg Cinacalcet Capsules) with 30 mg Commer... bad-data
Ongoing 2017-003236-37 High-Resolution Assessment of Coronary Plaques in a Global Evolocumab Randomized Study (HUYGENS) not-yet-due
Ongoing 2017-003512-40 A Randomized, Multicenter, Open-label, Parallel Group Study in Postmenopausal Women With Osteoporosis to Evaluate the Noninferiority of Subject-administered Romosozumab via Autoinjector/Pen vs Healthc... not-yet-due
No trial status on register 2017-003778-15 A Phase 1b/2 Study of Blinatumomab in Japanese Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL) (Horai Study) bad-data
Ongoing 2018-000550-21 Multicenter, Single-arm Open-label Extension Study to Assess Long term Safety and Efficacy of Current or Prior Treatment with Denosumab in Children/Young Adults with Osteogenesis Imperfecta not-yet-due
No trial status on register 2018-000923-15 A Phase I, Randomized, Open-label, Multiple-dose Study to Evaluate Safety, Tolerability, and Pharmacokinetics of AMG 334 in Children and Adolescents With Migraine bad-data